Stock Updates

Today’s Large Cap Details for Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) of Biotechnology

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), is firmly in the large market cap category with market cap of 54.43 B. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Regeneron Pharmaceuticals, Inc. is 503.82 (with a change from open of -0.71%), this in conjunction with a target price of 470.2. Volume today has so far reached 21170, with an average volume of about 992.02. The GAP for this stock, is 0.47%.

The P/E ratio is 60.76, bringing the forward P/E to a value of 33.19. The current EPS for Regeneron Pharmaceuticals, Inc., is 8.31, with a EPS growth for this year coming to a value of 39.50%. Performance has been interesting with performance year to date coming to 37.58%.

Looking further into the growth statistics for Regeneron Pharmaceuticals, Inc., EPS is looking like it will grow 19.55% in the next year. Looking even further it is projected to be 19.01%. Quarter over quarter is 36.20% for EPS growth and for sales growth quarter over quarter it is 9.80%. Looking at past EPS growth statistics we see that for the past five years it has been 38.80%. Sales growth for the past five years has in fact been 61.30%.

Looking at the ownership, we see that the insider ownership is at 1.00% and institutional ownership is 71.40%. Shares outstanding is 107.77, while shares float is at a value of 78.23. Float short for Regeneron Pharmaceuticals, Inc. is 3.65% and the short ratio is 2.88.

In terms of debt, long term debt/equity is 0.14, while the total debt/equity comes to 0.15. The ability to meet these debts, means that the current ratio is 2.8, and the quick ratio is 2.6. The most recent gross margin is 94.50% and their operating margin is 28.80%. The profit margin is 19.30%.

Regeneron Pharmaceuticals, Inc. has seen returns on assets of 13.80%, and on investment, 18.20%. Return on equity is 21.50%. Price/Earnings to growth ratio is 3.2. Price/Sales ratio is at a value of 10.93, with Price/book ratio coming to 10.96 and Price/cash is 41.64, and finally Price/Free cash Flow is 38.86.

The simple moving averages are 1.17% and 25.76% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -7.31% and the 52 week low is 54.85%.

Regeneron Pharmaceuticals, Inc. has a dividend yield of *TBA, with a current price of 503.82. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Regeneron Pharmaceuticals, Inc. is based in USA.

Performance in the Biotechnology industry means that Regeneron Pharmaceuticals, Inc. has seen performance for the past week of 3.03%, with performance for the month coming to 6.62%. Looking at the data for the quarter it is at a value of 37.87%, and for the half year the performance is 38.56%. Volatility for this week is 2.66% and for the month this is 3.50%.

REGN

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment